Is hypertension an inflammatory disease?

Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension (2008) 2.09

Periodontal disease, hypertension, and blood pressure among older adults in Puerto Rico. J Periodontol (2012) 1.54

The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6. Am J Physiol Regul Integr Comp Physiol (2009) 0.98

Periodontal disease and incidence of hypertension in the health professionals follow-up study. Am J Hypertens (2012) 0.85

Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat. Hypertension (2011) 0.82

Circulatory syndrome: an evolution of the metabolic syndrome concept! Curr Cardiol Rev (2012) 0.78

Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension (2016) 0.77

Is atrial fibrillation an inflammatory disease? Med Hypotheses (2005) 0.77

Changes of gene expressions in spontaneously hypertensive rat model after losartan treatment. Korean Circ J (2012) 0.77

Regional association-based fine-mapping for sodium-lithium countertransport on chromosome 10. Am J Hypertens (2008) 0.77

Plasma Inflammatory Markers and the Risk of Developing Hypertension in Men. J Am Heart Assoc (2015) 0.76

Investigation of relationship between IL-6 gene variants and hypertension in Turkish population. Cytotechnology (2014) 0.75

Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep (2017) 0.75

C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses (2004) 1.13

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med (2005) 1.11

Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med (2006) 1.10

Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Clin Cardiol (2003) 0.91

Activation of nuclear factor-kappaB and correlation with elevated plasma c-reactive protein in patients with unstable angina. Heart Lung Circ (2004) 0.88

Time course of rapid C-reactive protein reduction by pravastatin in patients with stable angina. Angiology (2006) 0.87

Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina. Clin Chim Acta (2005) 0.82

Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile. Angiology (2002) 0.81

Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis. Clin Chim Acta (2004) 0.81

Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina. Clin Chem (2005) 0.80

Ischemic preconditioning detected by treadmill exercise tests in patients with stable angina. Angiology (2003) 0.79

Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis. Med Hypotheses (2004) 0.78

Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis. Angiology (2004) 0.77

Statin, like aspirin, should be given as early as possible in patients with acute coronary syndrome. Med Hypotheses (2005) 0.77

Effects of simvastatin on exercise-induced myocardial ischemia and plasma endothelin-1 concentrations in patients with stable angina. Clin Chim Acta (2004) 0.75

Circadian variation in ischemic threshold in patients with stable angina: relation to plasma endothelin-1. Angiology (2002) 0.75

Takayasu's arteritis accompanied with pericarditis: a case report. Cardiology (2004) 0.75